LSN-2313136

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLSN-2313136
Drug Alias NamemGLUR 2 potentiator/CysLT 1 antagonist (Eli Lilly/Array Biopharma)metabotropic glutamate-2 receptor potentiator/cysteinyl leukotriene receptor-1 antagonist (Eli Lilly/Array Biopharma)LSN-2313136
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 agonistsCysteinyl leukotriene receptor 1 antagonists
TargetsMetabotropic glutamate receptor 2Cysteinyl leukotriene receptor 1
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyArray Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A